Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Samantha M. South"'
Autor:
Vince W. Clark, Bruno P. Meloni, Neville W Knuckey, Rajiv Bhalla, Ryan S. Anderton, Karine Mardon, Li Shan Chiu, Samantha M South
Publikováno v:
Future Drug Discovery. 2
Aim: R18D is a poly-arginine peptide that has demonstrated neuroprotection in preclinical models of excitotoxicity, stroke, hypoxic-ischemic encephalopathy and traumatic brain injury. Here, we examined the peptide’s uptake in serum. Materials & met
Autor:
Ryan S. Anderton, Samantha M South, Joseph Y. Nashed, Frank L. Mastaglia, Bruno P. Meloni, David Blacker, Andrew Winterborn, Neville W. Knuckey, Yining Chen, Douglas J. Cook, Kathleen A. Harrison
Publikováno v:
Neurotherapeutics
Poly-arginine peptide-18 (R18) is neuroprotective in different rodent middle cerebral artery occlusion (MCAO) stroke models. In this study, we examined whether R18 treatment could reduce ischemic brain injury and improve functional outcome in a nonhu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f205ec8d40d6f29725c802531a8d8c8d
https://europepmc.org/articles/PMC7283416/
https://europepmc.org/articles/PMC7283416/
Autor:
Amber L. Marriott, Neville W. Knuckey, David Blacker, Angela Jacques, Robert A. Déziel, Samantha M South, Daphne A. Gill, Bruno P. Meloni
Publikováno v:
Stroke. 50
Aims: We have previously demonstrated that the poly-arginine peptides R18 and R18D are neuroprotective at 24 hours following intraluminal middle cerebral artery occlusion (MCAO) in the rat. Therefore, using an independent laboratory we examined the a
Autor:
Ryan Reinders, Samantha M South, Bruno P. Meloni, Neville W. Knuckey, Lane J Liddle, David Blacker, Frederick Colbourne
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 11, p e0224870 (2019)
PLoS ONE, Vol 14, Iss 11, p e0224870 (2019)
Background Cationic arginine-rich peptides (CARPs) have demonstrated neuroprotective and/or behavioural efficacy in ischemic and hemorrhagic stroke and traumatic brain injury models. Therefore, in this study we investigated the safety and neuroprotec
Autor:
Qinghao Xu, Michael J. Glass, Laarni Quimson, Samantha M. South, Deborah M. Hegarty, Martin Oselkin, Virginia M. Pickel, Charles E. Inturrisi
Publikováno v:
Experimental Neurology. 213:57-70
Preclinical behavioral pharmacological and neuropharmacological evidence indicates that the NMDA receptor plays an important role in opioid dependence, however, the neural substrates subserving these actions are poorly understood. The central nucleus
Autor:
Hsinlin T Cheng, Qinghao Xu, Megumi Ohata, Samantha M. South, Masahiro Suzuki, Deborah M. Hegarty, Amanda R. Weyerbacher, Charles E. Inturrisi
Publikováno v:
Neuroscience. 155:948-958
The N-methyl-d-aspartate (NMDA) receptor in the spinal cord dorsal horn (SCDH) is one of the mechanisms involved in central sensitization during chronic pain. Previously, this laboratory created a spatio-temporal knockout (KO) of the N-methyl-d-aspar
Publikováno v:
The Journal of Pain. 6:809-816
For the pharmacokinetic evaluation of Silastic capsules, ovariectomized (OVX) rats were implanted subcutaneously with this dosage form containing 17beta-estradiol (5, 10, 15, or 20% in cholesterol, where 5% 17beta-estradiol equals 0.4 mg) or progeste
Autor:
Shirzad Jenab, Fred H. Gage, Johanna J. Bogulavsky, Andreas W. Sailer, Tony L. Yaksh, Megumi Ohata, Stephen F. Heinemann, Samantha M. South, Tatsuro Kohno, Shelle Malkmus, Charles E. Inturrisi, Carrie T. Drake, Bryce Vissel, Brian K. Kaspar, Deborah M. Hegarty, Philip J. Horner, Takashi Masuyama, Clifford J. Woolf
Publikováno v:
The Journal of Neuroscience. 23:5031-5040
To determine the importance of the NMDA receptor (NMDAR) in pain hypersensitivity after injury, the NMDAR1 (NR1) subunit was selectively deleted in the lumbar spinal cord of adult mice by the localized injection of an adenoassociated virus expressing
Publikováno v:
The journal of pain. 8(4)
A subcutaneous implant of 17β-estradiol or progesterone provides steady-state serum hormone levels from 7 to 24 days after implantation and allows the evaluation of the effects of the replacement with these hormones on phase 1 and phase 2 formalin-i